**Study Overview:** This clinical trial explores if CIN-102, a medicine called deudomperidone, can help reduce nausea in adults with idiopathic gastroparesis. Gastroparesis is a condition where the stomach takes too long to empty its contents, causing discomfort. The study will compare CIN-102's effectiveness and safety against a placebo, which is a harmless pill with no active medicine.
**Participation Process:**
- **Pre-screening and Screening Visits:** You will have 2-3 initial visits to check if you can join the study.
- **Treatment Duration:** The trial lasts for 12 weeks, requiring 7 visits, and involves taking the study drug twice daily.
- **Follow-up:** There's a final check-in one week after completing the treatment.
**Key Points:**
- You will need to complete a Gastric Emptying Breath Test (GEBT) and keep a daily diary.
- Participants must be 18 years or older with delayed stomach emptying, but without certain conditions like diabetes or recent gastric surgery.
- The study excludes those with substance use disorders or who need feeding tubes.
Make sure you're comfortable with the study schedule and requirements before deciding to participate.
How understandable was the trial content above?
Hard to understand
Easy to understand